Letters
Post-colonoscopy colorectal cancer
Post-colonoscopy colorectal cancer: patients can be reassured that UK endoscopy is already engaged in quality assessment and continual improvement
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6910 (Published 10 December 2019) Cite this as: BMJ 2019;367:l6910- Christopher J Healey, chair1,
- Siwan Thomas-Gibson, chair2
- 1Endoscopy Services Quality Assurance Group, Royal College of Physicians, London NW1 4LE, UK
- 2Joint Advisory Group on Gastrointestinal Endoscopy, Royal College of Physicians, London NW1 4LE, UK
- Chris.Healey{at}anhst.nhs.uk
Burr and colleagues suggest that quality improvement is needed to reduce variation in colonoscopy performance, as measured by post-colonoscopy colorectal cancer (PCCRC).1 This inter-hospital variation in colonoscopy quality has been known to UK gastroenterology since being shared by Roland Valori during the 2014 British Society of Gastroenterology (BSG) annual meeting. The importance of ensuring that colonoscopy does find bowel cancer consistently …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.